Castle Biosciences (CSTL) Goodwill & Intangibles (2018 - 2026)

Castle Biosciences has disclosed Goodwill & Intangibles across 7 years of filings, most recently posting $97.3 million for Q1 2026.

• Goodwill & Intangibles for Q1 2026 came in at $97.3 million, up 24.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $97.3 million (up 24.96% YoY), and the FY2025 annual result was $99.6 million, down 6.26% from the prior year.
• Goodwill & Intangibles came in at $97.3 million for Q1 2026 at Castle Biosciences, down from $99.6 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $132.7 million in Q2 2022 to a low of $77.9 million in Q1 2025.
• The 5-year median for Goodwill & Intangibles is $112.8 million (2024), against an average of $110.9 million.
• Across the five-year window, Goodwill & Intangibles surged 306.05% in 2022 and sank 32.31% in 2025, its largest moves.
• Castle Biosciences' Goodwill & Intangibles stood at $126.3 million in 2022, then declined by 7.13% to $117.3 million in 2023, then retreated by 9.47% to $106.2 million in 2024, then decreased by 6.26% to $99.6 million in 2025, then decreased by 2.24% to $97.3 million in 2026.
• The last three Goodwill & Intangibles figures came in at $97.3 million (Q1 2026), $99.6 million (Q4 2025), and $101.8 million (Q3 2025), per Business Quant data.